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Abstract
Objective—To determine maternal risk factors for stillbirth among pregnant HIV-infected women
in sub-Saharan Africa.
Design—Prospective cohort study nested within a micronutrient trial. At enrollment, maternal
sociodemographic, obstetric, immunologic, clinical, and nutritional variables were measured.
Women were followed through monthly clinic visits until delivery. Multivariate predictors of
stillbirth were identified in Poisson regression models.
Setting—Antenatal clinic in a tertiary care hospital in urban Dar es Salaam, Tanzania.
Population—N = 1,078 women enrolled between 12 and 27 weeks of gestation.
Main outcome measures—Stillbirth (delivery of dead baby ≥ 28 weeks’ gestation), fresh
stillbirth, and macerated stillbirth.
Results—Among 1,017 singleton pregnancies, there were 49 stillbirths, yielding a stillbirth risk of
50.0 per 1,000 deliveries (95% Confidence Interval(CI) = 37.2, 65.6). Of stillbirths with known type,
53.7% were fresh and 46.3% macerated. In multivariate analyses, baseline measures of late ( ≥ 21
weeks’ gestation) study entry (Relative Risk (RR) = 2.13, 95% CI = 1.17, 3.87), CD3 count ≥ 1,179
cells/ml (RR = 2.15, 95% CI = 1.16, 4.01), stillbirth history (RR = 3.53, 95% CI = 1.30, 9.59),
primiparity (RR = 3.65, 95% CI = 1.83, 7.29), and syphilis infection (RR = 2.06, 95% CI = 1.09,
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3.88) predicted increased stillbirth risk. Late study entry, illiteracy, stillbirth history, primiparity,
CD3 count ≥ 1,179 cells/ml, gonorrhea infection, and previous hospitalization predicted increased
risk of fresh stillbirth, while living alone and syphilis infection predicted increased risk of macerated
stillbirth.
Conclusions—Applying antenatal screening and preventive tools for the socioeconomic, obstetric,
immunologic, and clinical risk factors identified may assist in reducing the high incidence of stillbirth
among HIV-infected women in urban sub-Saharan Africa.
Keywords
Predictors; pregnancy; HIV; stillbirth; Tanzania
Introduction
Worldwide, more than 3.3 million stillbirths occur each year. Developing countries account
for over 97% of these deaths, while sub-Saharan Africa, the geographic region with the highest
incidence of stillbirth in the world, contributes more than one-fourth to the worldwide total
(1).
Maternal HIV infection may increase the risk of stillbirth (2). Given that 13 million women of
reproductive age currently live with HIV in sub-Saharan Africa (3), HIV infection and its
ramifications may account for a high toll of stillbirths. Nevertheless, little is known on
predictors of stillbirth among HIV-infected women (4).
Moreover, no studies among HIV-infected women have comprehensively assessed etiologic
factors separately for macerated stillbirths, which occur antepartum, and fresh stillbirths, which
generally occur intrapartum. This separation is important, as the causes of endpoints may vary
over the course of pregnancy (5). Inadequate access to vital obstetric care is an important risk
factor for intrapartum stillbirth in sub-Saharan Africa (6), whereas chromosomal abnormalities,
infection, and maternal demographic and behavioral factors may underlie antepartum stillbirths
(7).
Identifying risk factors for stillbirth among HIV-infected women could inform specific
preventive and curative actions during antenatal care (8). Therefore, we examined a wide range
of maternal predictors of overall stillbirth risk, as well as of risks of macerated and fresh
stillbirth, in a cohort of 1,017 HIV-infected Tanzanian women.
Material and methods
The study design has been described in detail (9). Study participants were HIV-infected
pregnant women, presenting for the first prenatal visit between 12 and 27 weeks’ gestation,
were residents of Dar es Salaam, and intended to stay in the city until delivery and for a year
thereafter. Those who gave informed consent to participate in the trial were randomized to a
daily dose of one of the following regimens: (1) vitamin A + β-carotene (30 mg of beta carotene
+ 5,000 IU of preformed vitamin A); (2) vitamins B, C, and E (20 mg of vitamin B1, 20 mg of
vitamin B2, 25 mg of vitamin B6, 100 mg of niacin, 50 µg of vitamin B12, 500 mg of vitamin
C, 30 mg of vitamin E, and 0.8 mg of folic acid); (3) vitamins B, C, and E + vitamin A + β-
carotene; or (4) placebo. Participants were enrolled from April 1995 to July 1997.
In accordance with national guidelines for antenatal care at the time, during pregnancy all
women received 400 mg of ferrous sulfate (equivalent to 120 mg of ferrous iron) and folate (5
mg) daily for anemia prophylaxis, and weekly doses of 500 mg of chloroquine phosphate
(equivalent to 300 mg of chloroquine base) for malaria prophylaxis. Syphilis infection was
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treated with benzathine penicillin among women and their partners, while hypertension during
pregnancy was treated with methyldopa. Antiretroviral therapy to reduce the risk of mother-
to-child transmission of HIV or to slow HIV disease progression was not available at the time
of the study.
During the baseline visit, trained research nurses conducted structured interviews to collect
information on obstetric history and sociodemographic factors such as age, literacy, education,
marital status, living arrangements, and expenditure on food. They also collected information
on history of morbidities, symptoms, and hospitalizations during the current pregnancy. The
research staff aided women in the recollection of their date of last menstrual period. This date
was used to calculate gestational age and season at conception. Study physicians carried out a
complete medical examination and collected blood, urine, stool, and vaginal swab specimens.
The stage of HIV disease was assigned in accordance to the World Health Organization (WHO)
staging system (10). Trained nurses measured the women’s blood pressure (to the nearest 1
mmHg) and anthropometry. They measured height and mid-upper arm circumference to the
nearest 0.1 cm and weight to the nearest 100 g. Body mass index was calculated as weight (kg)/
height (m)2.
Study participants were followed during monthly visits to the clinic and were asked to deliver
at Muhimbili National Hospital, where they received care in accordance with the national
standard of care at the time.
Laboratory methods
Baseline specimens were used to determine the presence of HIV infection and levels of
hemoglobin, T-lymphocytes (total lymphocytes; CD3, CD4, and CD8 subsets), serum retinol,
serum vitamin E, and erythrocyte sedimentation rate. At baseline, the presence of malaria,
intestinal parasites, and sexually transmitted diseases was also determined.
HIV-1 serostatus was determined by ELISA (Well-cozyme, Murex Biotech. Ltd., Dartford,
UK) and positive results were confirmed by the Western blot test (Bio-Rad Laboratories Ltd.,
Herfordshire, UK). Hemoglobin concentrations were measured by the CBC5 Coulter Counter
(Coulter Corp., Miami, FL) or the cyanmethaemoglobin colorimetric method (Corning Inc.,
Corning, NY). Absolute counts of T-lymphocytes were quantified with the FACS count system
(Becton-Dickinson, San Jose, CA). Serum retinol and vitamin E concentrations were
determined with high performance liquid chromatography (HPLC), and erythrocyte
sedimentation rate with the Westergren method.
Active syphilis was defined as positive results for sera antibodies in the Venereal Diseases
Research Laboratory (VDRL) slide test (Murex Diagnostic, Dartford, UK) or the Treponema
palladium hemag-glutination (TPHA, Fujirebio, Tokyo, Japan) test. Vaginal and cervical
swabs were examined for infection by Neisseria gonorrhea, Candida albicans, and
Trichomonas vaginalis. The presence of malaria parasites was ascertained from Giemsa-
stained thick and thin smear blood films. The level of parasite density per cubic millimeter was
estimated from the number of malarial parasites identified per 300 leukocytes and assuming a
leukocyte count of 8,000/mm3 of blood. Stool specimens were examined for the presence of
pathogenic protozoans and helminths. Macroscopic examinations were conducted for worms,
whereas eggs, trophozites, and cysts were detected microscopically using saline and iodine wet
mount, and the formalin-ether concentration technique.
Outcome definitions
Stillbirth was defined as the delivery of a dead baby ≥ 28 weeks’ gestation, in accordance with
previous work in this setting (9,11). Fresh stillbirths were characterized as death at birth without
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signs of skin disintegration or maceration; deaths with such signs were characterized as
macerated stillbirths (12). Miscarriages (delivery <28 weeks’ gestation) and live births born
at <28 weeks’ gestation were not in the risk set for stillbirths.
Data analyses
A total of 1,078 women participated in the parent multivitamin supplementation trial. Of the
1,041 (97%) women with a known pregnancy outcome, the 1,017 (94.3%) with singleton
pregnancies constituted the study cohort.
Maternal predictors were evaluated at the baseline visit, which occurred between 12 and 27
weeks’ gestation. Conventional cutoffs were used to categorize predictors; when these were
not available, the median was used to classify variables, in line with previous publications by
our group. Poisson regression models with robust variance were used to estimate relative risks
and 95% Confidence Intervals (CIs). Variables with univariate p < 0.2 were included in
multivariate regression models and retained if p < 0.05. We used time-varying Cox proportional
hazards models to determine whether predictors varied significantly between final models for
fresh and macerated stillbirth.
Observations with missing data were kept in analyses using the missing indicator method
(13). Given that the multivitamin regimen tested in the original trial significantly reduced the
risk of stillbirth (9), we included an indicator variable for receipt of multivitamin trial regimen
in all regression models. For stillbirth incidence, 95% CIs were calculated using exact methods
for binomial proportions. Statistical significance was defined as p < 0.05. Statistical analyses
were performed using SAS software version 9.1 (SAS Institute Inc., Cary, NC).
The study was approved by the College Research and Publications Committee of Muhimbili
University College of Health Sciences (now the Institutional Review Board at Muhimbili
University of Health Sciences and Allied Sciences), the ethics committee of the National AIDS
Control Program of the Tanzanian Ministry of Health, and the Institutional Review Board of
the Harvard School of Public Health.
Results
On average, women were 24.7 (SD = 4.8) years old and entered the study at 20.4 (SD = 3.3)
weeks’ gestation (Table I). Primiparas comprised 36.5% of the cohort; among multiparas,
10.8% had a history of stillbirth. The mean CD4 cell count was 420 (SD = 203) cells/mm3 and
most women (80.6%) were at HIV Stage I. The prevalence of sexually transmitted diseases at
baseline was 38.1%.
Of the 1,017 singleton pregnancies, 49 resulted in stillbirths, yielding a stillbirth risk of 50.0
(95% CI: 37.2, 65.6) per 1,000 deliveries (Figure 1). There were 22 (44.9%) fresh stillbirths
and 19 (38.8%) macerated stillbirths; the timing was unknown for 8 (16.3%). Among all
stillbirths, 35 (71.4%) were preterm and 14 (28.6%) were term. The mean gestational age at
birth was lower for stillbirths (34.4 weeks, SD = 4.4) compared to livebirths (38.7 weeks, SD
= 3.1) ( p < 0.0001).
In multivariate analyses examining risk factors for stillbirth, an approximately two-fold
increased risk of stillbirth was noted among women with entry into the study ≥ 21 weeks
gestation, CD3 cell count ≥ 1,179 cells/mm3, and syphilis infection (Table II). Previous
stillbirth and primiparity were related to approximately 3.5-fold increased risks in comparison
to multiparas without previous stillbirth. When macerated stillbirths were examined separately,
not living with a partner and syphilis infection were identified as significant multivariate risk
factors (Table III). In multivariate analyses for fresh stillbirth, significant risk factors were
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entry into the study ≥ 21 weeks gestation, illiteracy, previous stillbirth, primiparity, CD3 cell
count ≥ 1,179 cells/mm3, gonorrhea infection, and previous hospitalization during the same
pregnancy (Table IV).
Time-varying analyses comparing predictors of macerated and fresh stillbirths also
demonstrated that syphilis infection was a significant risk factor for macerated, but not fresh
stillbirth ( p = 0.05). There were no other significant interactions when comparing predictors
for macerated stillbirth with those for fresh stillbirth.
Discussion
We assessed the incidence of stillbirth and its sociodemographic, obstetric, immunologic,
clinical, and nutritional determinants among HIV-infected Tanzanian women. The risk of
stillbirth among these women was 50 per 1,000 deliveries. This risk is higher than the aggregate
risk for sub-Saharan Africa, estimated at 32 per 1,000 births, which is the highest of all regions
in the world (14). HIV infection may account for this higher risk (2); however, risk of fetal
loss (including both miscarriages and stillbirths) in the present study cohort did not differ from
the risk in a contemporaneous cohort of HIV-uninfected women (15). The higher risk in our
cohort may be due to better documentation than in population-based estimates, which are likely
to underestimate the true risk of stillbirth (1).
In this cohort, 71.4% of stillbirths occurred before 37 weeks’ gestation. Other studies support
that the majority of stillbirths occur preterm (16). For instance, Chi et al. described that 66%
of stillbirths occurred preterm in a multicenter study from sub-Saharan Africa among
predominantly HIV-infected women (4). The proportion of fresh stillbirths in our study was
four to five times higher than in developed countries, but was similar to that described by Chi
et al. (4). The higher proportion of fresh stillbirths in sub-Saharan Africa is likely caused by
deficiencies in care during delivery (7).
Late entry into the trial( ≥ 21 weeks’ gestation) was related to an increased risk of stillbirth
overall and of fresh stillbirth. Women entered the trial after their first antenatal visit, so that
entry into the trial is related to the duration of antenatal care. Thus, it appears that the duration
of antenatal care was of benefit. Similarly, in a study from Brazil, fewer antenatal visits were
related to an increased risk of stillbirth (17). Nevertheless, it is unclear whether the content of
antenatal care was the causal factor for improved reproductive outcomes, or whether women
who reported early represented a lower-risk group.
Illiteracy was related to increased risks of fresh stillbirth. Poor socioeconomic and educational
status is associated with increased risk of stillbirth (18,19), partly because women with low
socioeconomic status are less likely to make use of antenatal care, even if it is officially free
as in Tanzania (20).
Living without a partner was related to an increased risk of macerated stillbirth. In North
America, pregnancy outcomes are poorer among single women compared to those who are
married or unmarried but cohabiting (21). The underlying factors are unknown, but may relate
to increased stress level during pregnancy, harmful behaviors during pregnancy, or poorer
socioeconomic status among single women (21). These factors may also be at work in our
setting.
Maternal syphilis infection at baseline was strongly related to stillbirths overall and to
macerated but not fresh stillbirths. The causative agent, T. pallidum, may be transmitted to the
fetus transplacentally and may decrease blood flow to the fetus (22). However, we were unable
to perform placental assessments and, therefore, unable to confirm these mechanisms. Up to
half of all stillbirths may be due to syphilis among unscreened women in Tanzania, and
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treatment for serological syphilis during pregnancy can reduce the risk of adverse pregnancy
outcomes to that of seronegative women (23). It is unclear why syphilis infection remained
predictive of macerated stillbirth in our study despite the availability of treatment. One possible
explanation is that fetal infection had already occurred by the time women were recruited into
the study; alternatively, some women may have reacquired the infection after the initial
treatment.
Gonorrhea infection was related to fresh stillbirth in this study. This infection is generally not
considered to be a risk factor for abortion and stillbirth; however, gonorrhea has been associated
with prematurity and low birth weight (24). Our findings indicate that gonorrhea infection may
also be a risk factor for fresh stillbirth among HIV-infected women, but the number of endpoints
to examine this association was small.
A history of stillbirth was a strong risk factor for stillbirth. This is in line with evidence from
different settings that describe a strong disposition to repeat adverse reproductive outcomes
(16). Primiparity was a risk factor of similar magnitude. Possibly, primiparous women are less
aware to detect warning signs during pregnancy. In North America, improved access to and
quality of antenatal as well as obstetric care has reduced the risk of reproductive failure among
primiparous women to that of multiparous women (25). In our setting, primiparity and a history
of reproductive failure should trigger special attention during antenatal care while care overall
improves.
Elevated CD3 cell count was related to increased risks of stillbirth overall and of fresh stillbirth.
The CD3 complex is expressed on CD4 and CD8 cells as well as their immature precursor cells
(26). Higher CD3 cell counts may suggest prior exposure to infectious agents or advanced stage
of HIV disease, which may result in a higher risk of stillbirth. The lack of association between
stillbirth and other markers of advanced HIV disease stage, such as elevated CD8 cell count
or reduced CD4 count, does not support an association between advanced disease stage and
stillbirth, though. Chance may therefore serve as an alternative explanation of the observed
association.
Malarial infection at baseline was not related to risk of stillbirth. Malaria infection during
pregnancy increases the risk of preterm delivery and low birth weight (27,28), but only active
placental malaria appears to increase the risk of stillbirth (29). Even though HIV infection
increases the risk of malaria during pregnancy (30), our findings are in line with other evidence
that maternal malaria does not independently predict reproductive failure.
Maternal anemia early in pregnancy is related to increased risks of low birth weight and
prematurity among HIV-uninfected women (31) and may also increase stillbirth risk (32).
There is little evidence from HIV-infected populations, and our current analyses indicate that
maternal anemia in the first two trimesters is not predictive of fetal loss.
We described high risks of reproductive failure in this cohort of HIV-infected pregnant and
we were able to identify maternal risk factors not only for macerated stillbirth, which have
traditionally been related to pregnancy complications or maternal disease, but also for fresh
stillbirth. In particular, our results indicate that among HIV-infected women from sub-Saharan
Africa, improving intrapartum care needs renewed attention and that initiation of antepartum
care in the first half of pregnancy may be beneficial. Our findings support the benefit of
improving maternal immunologic status and the prevention and treatment of syphilis and
gonorrhea for pregnancy outcomes. Implementing these interventions into antenatal care may
reduce the unacceptably high incidence of stillbirths among HIV-infected women in sub-
Saharan Africa.
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Figure 1.
Study profile.
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Table I
Background characteristics at baseline.
Characteristic
Women with
baseline data (n) Mean (SD) or%
Age (years) 1,017 24.7 (4.8)
Gestational age at study
    entry (weeks)
1,017 20.4 (3.3)
Literacy (%) 1,012 91.6
Primiparity (%) 948 36.5
History of stillbirth (%)a 631 10.8
CD4 cell count 956 420 (203)
HIV stage ≥ 2 (%) 1,015 80.6
Presence of sexually
    transmitted disease (%)b
985 38.1
Height (cm) 1,001 156.6 (5.9)
Mid-upper arm
    circumference (cm)
914 25.6 (2.9)
Hemoglobin (g/dl) 999 9.4 (1.7)
a
Among multiparous women.
b
Defined as infection with Treponema palladium, Neisseria gonorrhea, or Trichomonas vaginalis.
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